[1]
P. Colucci, J. Turgeon, and M. P. Ducharme, “How Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence?”, J Pharm Pharm Sci, vol. 14, no. 2, pp. 217–226, Jun. 2011.